Business Segments · Expected costs remaining
Corporate — Expected costs remaining
This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ4 2020
Last reportedQ4 2025
Rolls up toRestructuring Reserve
How to read this metric
A declining balance indicates that the restructuring program is nearing completion.
Detailed definition
This represents the portion of total authorized restructuring budgets that has not yet been recognized as an expense. It...
Peer comparison
Often disclosed in the footnotes regarding restructuring reserves and future cash requirements.
Metric ID:
xyl_segment_corporate_expected_costs_remainingHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | -$1.00M | $0.00 | $9.00M |
| QoQ Change | — | — | — | +100.0% | — |
| YoY Change | — | — | — | +100.0% | — |
Range-$1.00M – $9.00M
Avg YoY Growth+100.0%
Median YoY Growth+100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Xylem's corporate — expected costs remaining?
- Xylem (XYL) reported corporate — expected costs remaining of $9.00M in Q4 2025.
- What does corporate — expected costs remaining mean?
- The remaining portion of the total planned restructuring budget that has not yet been spent.